diltiazem has been researched along with Metabolic Skin Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dennin, MH; Dulmage, BO; Keimig, E; Yazdan, P | 1 |
| Abdoucheli-Baudot, N; Gaitz, JP; Hidouche, D; Vayssairat, M | 1 |
2 other study(ies) available for diltiazem and Metabolic Skin Diseases
| Article | Year |
|---|---|
Metastatic calcinosis cutis in a patient with Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcinosis; Calcium Channel Blockers; Diltiazem; Female; Hodgkin Disease; Humans; Hypercalcemia; Neoplasm Staging; Skin Diseases, Metabolic | 2018 |
Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression?
Topics: Autoantibodies; Calcinosis; Calcium Channel Blockers; Capillaries; Centromere; Diltiazem; DNA Topoisomerases, Type I; Female; Humans; Male; Middle Aged; Nuclear Proteins; Retrospective Studies; Scleroderma, Systemic; Skin; Skin Diseases, Metabolic; Treatment Failure | 1998 |